Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study

Objective(s): To investigate the efficiency of a novel series of coumarin derivatives bearing benzoheterocycle moiety as novel cholinesterase inhibitors. Materials and Methods: Different 7-hydroxycoumarin derivatives were synthesized via Pechmann or Knoevenagel condensation and conjugated to different benzoheterocycle (8-hydroxyquinoline, 2-mercaptobenzoxazole or 2-mercaptobenzimidazole) using dibromoalkanes 3a-m: Final compounds were evaluated against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) by Ellman’s method. Kinetic study of AChE inhibition and ligand-protein docking simulation were also carried out for the most potent compound 3b. Results: Some of the compounds revealed potent and selective activity against AChE. Compound 3b containing the quinoline group showed the best activity with an IC50 value of 8.80 μM against AChE. Kinetic study of AChE inhibition revealed the mixed-type inhibition of the enzyme by compound 3b. Ligand-protein docking simulation also showed that the flexibility of the hydrophobic five carbons linker allows the quinoline ring to form π-π interaction with Trp279 in the PAS. Conclusion: We suggest these synthesized compounds could become potential leads for AChE inhibition and prevention of AD symptoms.

• Publication year

  2017

• Venue

  Iranian Journal of Basic Medical Sciences

• Publication date

  2017-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.22038/IJBMS.2017.8830PMID 28868119PMCID 5569448
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2-(2-(4-Benzoylpiperazin-1-yl)ethyl)isoindoline-1,3-dione derivatives: Synthesis, docking and acetylcholinesterase inhibitory evaluation as anti-alzheimer agents

  2017cited by this paper
• Synthesis and anticholinesterase activity of coumarin-3-carboxamides bearing tryptamine moiety.

  2016cited by this paper
• Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives.

  2014cited by this paper
• Recent Advances in the Synthesis of Coumarin Derivatives via Knoevenagel Condensation: A Review

  2014cited by this paper
• Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors.

  2013cited by this paper
• Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.

  2013cited by this paper
• Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.

  2013cited by this paper
• Novel coumarin derivatives bearing N-benzyl pyridinium moiety: potent and dual binding site acetylcholinesterase inhibitors.

  2012cited by this paper
• Tacrine-ferulic acid-nitric oxide (NO) donor trihybrids as potent, multifunctional acetyl- and butyrylcholinesterase inhibitors.

  2012cited by this paper
• Inhibition of cholinesterase activity and amyloid aggregation by berberine-phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids.

  2012cited by this paper
• Substrate specificity of acetoxy derivatives of coumarins and quinolones towards Calreticulin mediated transacetylation: investigations on antiplatelet function.

  2012cited by this paper
• Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.

  2012cited by this paper
• Study on the Anticancer Activity of Coumarin Derivatives by Molecular Modeling

  2011cited by this paper
• Coumarins as antioxidants.

  2011cited by this paper
• Open Babel: An open chemical toolbox

  2011cited by this paper
• Inhibitory effect of esculetin on migration, invasion and matrix metalloproteinase-9 expression in TNF-α-induced vascular smooth muscle cells.

  2011cited by this paper
• Alzheimer's disease.

  2010cited by this paper
• Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.

  2010cited by this paper
• Tacrine derivatives and Alzheimer's disease.

  2010cited by this paper
• Current Treatments for Patients With Alzheimer Disease

  2010cited by this paper
• AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

  2009cited by this paper
• Cholinesterase inhibitors and beyond.

  2009cited by this paper
• Cholinesterase inhibition: is there evidence for disease-modifying effects?

  2009cited by this paper
• Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds.

  2008cited by this paper
• Inhibition of acetylcholinesterase by coumarins: the case of coumarin 106.

  2008cited by this paper
• Coumarin derivatives protection against ROS production in cellular models of Aβ toxicities

  2007cited by this paper
• UCSF Chimera—A visualization system for exploratory research and analysis

  2004cited by this paper
• Cholinesterase inhibitors: new roles and therapeutic alternatives.

  2004cited by this paper
• Treatment of Alzheimer's disease: current status and new perspectives.

  2003cited by this paper
• Clinically tested drugs for Alzheimer’s disease

  2003cited by this paper
• Peripheral site ligands accelerate inhibition of acetylcholinesterase by neutral organophosphates

  2001cited by this paper
• Python: a programming language for software integration and development.

  1999cited by this paper
• The influence of peripheral site ligands on the reaction of symmetric and chiral organophosphates with wildtype and mutant acetylcholinesterases.

  1999cited by this paper
• 6-Coumarin diazonium salt: a specific affinity label of the Torpedo acetylcholinesterase peripheral site.

  1995cited by this paper
• Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein

  1991cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper

• Enhanced gut microbiota delivery of a model probiotic (Faecalibacterium prausnitzii): Layer-by-layer encapsulation using riboflavin-conjugated sodium alginate and glycol chitosan

  2024cites this paper
• Synthesis and PASS-assisted evaluation of new heterocyclic compounds containing hydroquinoline scaffolds

  2024cites this paper
• Synthesis, biological evaluation and in silico study of 4-(benzo[d]thiazole-2-yl) phenols based on 4-hydroxy coumarin as acetylcholinesterase inhibitors

  2024cites this paper
• An overview of structure-based activity outcomes of pyran derivatives against Alzheimer’s disease

  2023cites this paper
• Umbelliferone and Its Synthetic Derivatives as Suitable Molecules for the Development of Agents with Biological Activities: A Review of Their Pharmacological and Therapeutic Potential

  2023cites this paper
• Recent advances on biologically active coumarin-based hybrid compounds

  2023cites this paper
• Novel Coumarin–Pyridine Hybrids as Potent Multi-Target Directed Ligands Aiming at Symptoms of Alzheimer’s Disease

  2022cites this paper
• Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease.

  2021cites this paper
• Novel aggregation induced emission based 7-(diethylamino)-3-(4-nitrophenyl)-2H-chromen-2-one for forensic and OLEDs applications

  2021cites this paper
• Coumarin linked heterocyclic hybrids: A promising approach to develop multi target drugs for Alzheimer's disease

  2021cites this paper
• Recent Advances in the Synthesis and Biological Activity of 8-Hydroxyquinolines

  2020cites this paper
• Diet therapy for the treatment of Alzheimer’s disease in view of traditional Persian medicine: A review

  2019cites this paper
• Critical evaluation of current Alzheimer's drug discovery (2018-19) & futuristic Alzheimer drug model approach.

  2019cites this paper
• Cholinesterase Inhibition Activity and Docking Simulation Study of Coumarin Mannich Base Derivatives

  2019cites this paper
• Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory.

  2019cites this paper
• Novel 3-phenylcoumarin-lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer's disease.

  2018cites this paper